A small number of individuals with ATXN2 mutations present with outlier phenotypes such as l-DOPA responsive parkinsonism or amyotrophic lateral sclerosis (ALS) indistinguishable from idiopathic forms of the respective diseases.13,14. This evidence concerns the gene ATXN2 and Parkinson disease.